Oligomerization of Ebola virus VP40 is essential for particle morphogenesis and regulation of viral transcription.
The morphogenesis and budding of virus particles represent an important stage in the life cycle of viruses. For Ebola virus, this process is driven by its major matrix protein, VP40. Like the matrix proteins of many other nonsegmented, negative-strand RNA viruses, VP40 has been demonstrated to oligomerize and to occur in at least two distinct oligomeric states: hexamers and octamers, which are composed of antiparallel dimers. While it has been shown that VP40 oligomers are essential for the viral life cycle, their function is completely unknown. Here we have identified two amino acids essential for oligomerization of VP40, the mutation of which blocked virus-like particle production. Consistent with this observation, oligomerization-deficient VP40 also showed impaired intracellular transport to budding sites and reduced binding to cellular membranes. However, other biological functions, such as the interaction of VP40 with the nucleoprotein, NP, remained undisturbed. Furthermore, both wild-type VP40 and oligomerization-deficient VP40 were found to negatively regulate viral genome replication, a novel function of VP40, which we have recently reported. Interestingly, while wild-type VP40 was also able to negatively regulate viral genome transcription, oligomerization-deficient VP40 was no longer able to fulfill this function, indicating that regulation of viral replication and transcription by VP40 are mechanistically distinct processes. These data indicate that VP40 oligomerization not only is a prerequisite for intracellular transport of VP40 and efficient membrane binding, and as a consequence virion morphogenesis, but also plays a critical role in the regulation of viral transcription by VP40.
Hoenen
T
T
Institut für Virologie, Hans-Meerwein-Str. 2, 35043 Marburg, Germany.
Biedenkopf
N
N
Zielecki
F
F
Jung
S
S
Groseth
A
A
Feldmann
H
H
Becker
S
S
D002460:Cell Line; D002462:Cell Membrane / Q000378:metabolism; D029043:Ebolavirus / Q000502:physiology / Q000648:ultrastructure; D006801:Humans; D008958:Models, Molecular; D008969:Molecular Sequence Data; D009698:Nucleoproteins / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D055503:Protein Multimerization; D020836:Protein Structure, Quaternary; D014158:Transcription, Genetic; D020798:Two-Hybrid System Techniques; D014758:Viral Core Proteins / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D014771:Virion / Q000502:physiology* / Q000648:ultrastructure
D009698:Nucleoproteins; D014758:Viral Core Proteins; C084819:nucleoprotein VP40, Ebola virus
J Virol. 2009 Oct;83(20):10374-83
19656884
J Virol. 2001 Jun;75(11):5205-14
11333902
Structure. 2003 Apr;11(4):423-33
12679020
Electrophoresis. 1997 Dec;18(15):2714-23
9504803
J Mol Biol. 2000 Jun 30;300(1):103-12
10864502
J Virol. 2010 Mar;84(5):2294-303
20032189
J Infect Dis. 2007 Nov 15;196 Suppl 2:S284-90
17940962
Mol Cell. 2002 Aug;10(2):307-16
12191476
J Gen Virol. 2003 Jun;84(Pt 6):1613-1621
12771432
J Virol. 2007 Apr;81(7):3554-62
17229682
J Struct Biol. 2005 Jul;151(1):30-40
15908231
J Virol. 2003 Nov;77(22):12074-82
14581544
J Virol. 2006 Dec;80(24):12070-8
17005661
J Virol. 2003 Oct;77(19):10383-93
12970423
J Virol. 2006 Jul;80(14):7260-4
16809331
Virus Res. 2009 Mar;140(1-2):8-14
19041915
J Gen Virol. 2007 Apr;88(Pt 4):1243-1250
17374768
Virology. 2010 Jul 20;403(1):56-66
20444481
Virology. 2006 Jan 5;344(1):64-70
16364737
J Virol. 2001 Dec;75(24):12241-51
11711615
BMC Microbiol. 2003 Apr 04;3:6
12697055
J Virol. 1999 Mar;73(3):2333-42
9971816
FEBS Lett. 2005 May 9;579(12):2686-92
15862310
J Virol. 2002 May;76(10):4855-65
11967302
J Virol. 2006 Jun;80(11):5156-67
16698996
J Virol. 1979 Jan;29(1):134-42
219213
Proc Natl Acad Sci U S A. 1982 Dec;79(23):7137-41
6296818
EMBO J. 2000 Aug 15;19(16):4228-36
10944105
J Virol. 2003 Feb;77(3):1812-9
12525615
Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15936-41
14673115
J Virol. 2007 Oct;81(20):11452-60
17699576
PLoS Pathog. 2006 Sep;2(9):e99
17009868
J Virol. 2005 Aug;79(16):10300-7
16051823
Virology. 1998 Sep 30;249(2):406-17
9791031
J Virol. 2004 Jan;78(2):999-1005
14694131
Virology. 2003 Aug 1;312(2):359-68
12919741
J Virol. 2003 Sep;77(18):9987-92
12941909
Arch Virol Suppl. 1999;15:159-69
10470276
Virus Res. 2004 Dec;106(2):181-8
15567496
J Virol. 2005 Feb;79(3):1898-905
15650213
EMBO J. 2000 Dec 15;19(24):6732-41
11118208
Virus Res. 2004 Dec;106(2):133-45
15567493
Virus Res. 2004 Dec;106(2):117-32
15567492
J Mol Biol. 2003 Feb 14;326(2):493-502
12559917
Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):624-9
17202263
Virology. 2005 Feb 5;332(1):406-17
15661171